Modulation of genomic and postgenomic alterations in noncancer diseases and critical periods of life

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 667, Issue 1-2, 2009, Pages 15-26

  De Flora, Silvio ^a   Izzotti, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Ageing; Chemoprevention; Mutation related diseases; Perinatal period; Pregnancy; Stem cells

Indexed keywords

PROTEOME; TRANSCRIPTOME;

AGING; ALOPECIA; ARTICLE; ATHEROSCLEROSIS; CANCER RESEARCH; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIET THERAPY; DNA DAMAGE; EXPERIMENTAL STUDY; EYE DISEASE; GENETIC PREDISPOSITION; GENOME; GENOMICS; HEART DISEASE; HUMAN; METABOLIC SYNDROME X; NEUROLOGIC DISEASE; NONCANCER DISEASE; NONHUMAN; OXIDATIVE STRESS; PERINATAL PERIOD; PHYSICAL DISEASE; PRENATAL PERIOD; PRIORITY JOURNAL; SKIN DISEASE;

AGING; ANIMALS; CHRONIC DISEASE; DNA DAMAGE; DNA, MITOCHONDRIAL; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY;

EID: 67649205283     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.09.010     Document Type: Article

References (108)

1. De Flora S., Quaglia A., Bennicelli C., and Vercelli M. The epidemiological revolution of the 20th century. FASEB J. 19 (2005) 892-897
2. Peto R., and Doll R. There is no such thing as aging. Br. Med. J 315 (1997) 1030-1032
3. World Health Organization, International Statistical Classification of Diseases and related health problems, 10th revision, vol. 1, Geneva, Switzerland, World Health Organization, 1992.
4. Boone C.W., Kelloff G.J., and Steele V.E. Natural history of intrahepithelial neoplasia in humans with implications for cancer chemopreventive strategy. Cancer Res. 52 (1992) 1651-1659
5. S.C. Saccà, A. Izzotti, A. Bagnis, A. Battistella, C. Bolognesi, Gene-environment interactions in ocular diseases, Mutat. Res., this issue.
6. A. Izzotti, G.A. Calin, P. Arrigo, V.E. Steele, C.M. Croce, S. De Flora, Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke, FASEB J. 23 (2009) in press.
7. De Flora S., Izzotti A., Randerath K., Randerath E., Bartsch H., Nair J., Balansky R., van Schooten F.J., Degan P., Fronza G., Walsh D., and Lewtas J. DNA adducts in chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat. Res. 366 (1996) 197-238
8. D'Agostini F., Izzotti A., Balansky R., Bennicelli C., and De Flora S. Modulation of apoptosis by chemopreventive agents. Mutat. Res. 591 (2005) 173-186
9. A. Hirvonen, Gene-environment interactions in chronic pulmonary diseases, Mutat. Res., this issue.
10. L. Migliore, F. Coppedé, Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases, Mutat. Res., this issue, doi:10.1016/j.mrfmmm.2008.10.011.
11. M.G. Andreassi, Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interactions, Mutat. Res., this issue.
12. Tomatis L. Overview of perinatal and multigeneration carcinogenesis. In: Napalkov N.P., Rice J.M., Tomatis L., and Yamasaki H. (Eds). Perinatal and Multigeneration Carcinogenesis vol. 96 (1989), International Agency for Research on Cancer, Lyon, France 1-15 (IARC Sci. publ.)
13. Hansen C., Sorensen L.D., Asmussen I., and Autrup H. Transplacental exposure to tobacco smoke in human-adduct formation in placenta and umbilical cord blood vessels. Teratog. Carcinog. Mutagen. 12 (1992) 51-60
14. Perera F.P., Jedrychowski W., Rauh V., and Whyatt R.M. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ. Health Perspect. 107 (1999) 451-460
15. Balansky R., and Blagoeva P.M. Tobacco smoke-induced clastogenicity in mouse fetuses and in newborn mice. Mutat. Res. 223 (1989) 1-6
16. Karube T., Odagiri Y., Takemoto K., and Watanabe S. Analyses of transplacentally induced sister chromatid exchanges and micronuclei in mouse fetal liver cells following maternal exposure to cigarette smoke. Cancer Res. 49 1989 (1989) 3550-3552
17. 32P-postlabeling assay to study transplacental carcinogens and transplacental carcinogenesis. In: Napalkov N.P., Rice J.M., Tomatis L., and Yamasaki H. (Eds). Perinatal and Multigeneration Carcinogenesis vol. 96 (1989), International Agency for Research on Cancer, Lyon, France 189-204 (IARC Sci. publ.)
18. Upham B.L., Weis L.M., and Trosko J.E. Modulated gap injunctional intercellular communications as a biomarker of PAH epigenic toxicity: structure-function relationship. Environ. Health Perspect. 106 (1998) 975-981
19. World Health Organization, International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Tobacco smoke and involuntary smoking, vol. 83, Lyon, France, World Health Organization, 2004.
20. Izzotti A., Balansky R., Cartiglia C., Camoirano A., Longobardi M., and De Flora S. Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke. FASEB J. 17 (2003) 1127-1129 (full text available online, 22 April 2003)
21. De Flora S., Izzotti A., D'Agostini F., and Balansky R. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22 (2001) 999-1013
22. De Flora S., Izzotti A., Albini A., D'Agostini F., Bagnasco M., and Balansky R. Antigenotoxic and cancer preventive mechanisms of N-acetyl-l-cysteine. In: Kelloff G.J., Hawk E.T., and Sigman C.C. (Eds). Cancer Chemoprevention, Vol. 1: Promising Cancer Chemopreventive Agents (2004), The Humana Press Inc., Totowa, NJ 37-67
23. Idell S., and Cohen A.B. Alpha-1-antitripsin deficiency. Clin. Chest Med. 4 (1983) 359-375
24. Repine J.E., Bast A., Lankhorst I., and The oxidative stress group. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156 (1997) 341-357
25. Satoh K., Nukiwa T., Brantly M., Garver R.I., Hofker M., Courtney M., and Crystal R.G. Emphysema associated with complete absence of alpha 1-antitrypsin in serum and the homozygous inheritance of a stop codon in an alpha 1-antitrypsin-coding exon. Am. J. Hum. Genet. 42 (1988) 77-83
26. Hayes J.A., Christensen T.G., and Snider G.L. The hamster as a model of chronic bronchitis and emphysema in man. Lab. Anim. Sci. 27 (1977) 762-770
27. Nelson E., Goubet-Wiemers C., Guo Y., and Jodscheit K. Maternal passive smoking during pregnancy and fetal developmental toxicity. Part 2: Histological changes. Hum. Exp. Toxicol. 18 (1999) 257-268
28. Izzotti A., Balansky R., Camoirano A., Cartiglia C., Longobardi M., Tampa E., and De Flora S. Birth-related genomic and transcriptional changes in mouse lung. Modulation by transplacental N-acetylcysteine. Mutat. Res. 544 (2003) 441-449
29. Randerath E., Zhou G.D., and Randerath K. Organ-specific oxidative DNA damage associated with normal birth in rats. Carcinogenesis 17 (1996) 2563-2570
30. Randerath K., Zhou G.D., Monk S.A., and Randerath E. Enhanced levels in neonatal rat liver of 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-hydroxydeoxyguanosine), a major mutagenic oxidative DNA lesion. Carcinogenesis 18 (1997) 1419-1421
31. Sastre J., Asensi M., Rodrigo F., Pallardó F.V., Vento M., and Viña J. Antioxidant administration to the mother prevents oxidative stress associated with birth in the neonatal rat. Life Sci. 54 (1994) 2055-2059
32. Bonner A.E., Lemon W.J., and You M. Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J. Med. Genet. 40 (2003) 408-417
33. Horowitz R.S., Dart R.C., Jarvie D.R., Bearer C.F., and Gupta U. Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J. Toxicol. Clin. Toxicol. 35 (1997) 447-451
34. Anderson L.M. Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies. Toxicol. Appl. Pharmacol. 199 (2004) 85-90
35. Balansky R., Ganchev G., Iltcheva M., Steele V.E., D'Agostini F., and De Flora S. Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis 28 (2007) 2236-2243
36. De Flora S., D'Agostini F., Balansky R., Camoirano A., Cartiglia C., Longobardi M., Travaini G., Steele V.E., Pesce C., and Izzotti A. High susceptibility of neonatal mice to molecular, biochemical and cytogenetic alterations induced by environmental cigarette smoke and light. Mutat. Res. Rev. 659 (2008) 137-146
37. Izzotti A., D'Agostini F., Balansky R., Pennisi T.M., Steele V.E., and De Flora S. Exposure of mice to cigarette smoke and/or light causes DNA alterations in heart and aorta. Mutat. Res. 644 (2008) 38-42
38. Alexander P. The role of DNA lesions in the processes leading to aging in mice. Symp. Soc. Exp. Biol. 21 (1967) 29-50
39. Holmes G.E., Bernstein C., and Bernstein H. Oxidative and other DNA damages as the basis of aging: a review. Mutat. Res. 275 (1992) 305-315
40. Tan B.H., Bencsath A., and Gaubatz J.W. Steady-state levels of 7-methylguanine increase in nuclear DNA of postmitotic mouse tissues during aging. Mutat. Res. 237 (1990) 229-238
41. Saul R.L., and Ames B.N. Background levels of DNA damage in the population. In: Simic M.G., Grossman L., and Upton A.C. (Eds). Mechanisms of DNA Damage and Repair: Implications for Carcinogenesis and Risk Assessment (1986), Plenum, New York 529-536
42. Ames B.N., and Gold L.S. Endogenous mutagens and the causes of aging and cancer. Mutat. Res. 250 (1991) 3-16
43. Randerath K., Putman K.L., Osterburg H.H., Johnson S.A., Morgan D.G., and Finch C.E. Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutat. Res. 295 (1993) 11-18
44. Izzotti A., Cartiglia C., Taningher M., De Flora S., and Balansky R. Age-related increases of 8-hydroxy-2′-deoxyguanosine and DNA protein crosslinks in mouse organs. Mutat. Res. 446 (1999) 215-223
45. Miquel J., and Fleming J.E. A two-step hypothesis on the mechanisms of in vitro cell aging: cell differentiation followed by intrinsic mitochondrial mutagenesis. Exp. Gerontol. 19 (1984) 31-36
46. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases. Science 256 (1992) 628-632
47. Richter C., Park J.W., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6465-6467
48. Barja G., and Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J. 14 (2000) 312-318
49. Balansky R., Izzotti A., Scatolini L., D'Agostini F., and De Flora S. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res. 56 (1996) 1642-1647
50. Mimeault M., and Batra S.K. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev. 4 (2008) 27-49
51. Bixby S., Kruger G.M., Mosher J.T., Joseph N.M., and Morrison S.J. Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 35 (2002) 643-656
52. Sagar J., Chaib B., Sales K., Winslet M., and Seifalian A. Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int. 7 (2007) 9 (Published online 2007 June 4. doi:10.1186/1475-2867-7-9)
53. Dietrich J., Imitola J., and Kesari S. Mechanisms of disease: the role of stem cells in the biology and treatment of gliomas. Nat. Clin. Pract. Oncol. 5 (2008) 393-404
54. Sun W., Kang K.S., Morita I., Trosko J.E., and Chang C.C. High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization. Cancer Res. 59 (1999) 6118-6123
55. De Flora S., Scarfì S., Izzotti A., D'Agostini F., Chang C.-C., Bagnasco M., De Flora A., and Trosko J.E. Induction by 7,12-dimethylbenz(a)anthracene of molecular and biochemical alterations in transformed human mammary epithelial stem cells, and protection by N-acetylcysteine. Int. J. Oncol. 29 (2006) 521-529
56. Kao C.Y., Nomata K., Oakley C.S., Welsch C.W., and Chang C.C. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis 16 (1995) 531-538
57. Kang K.S., Sun W., Nomata K., Morita I., Cruz A., Liu C.J., Trosko J.E., and Chang C.C. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinog. 21 (1998) 225-233
58. + stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 9530-9535
59. Braido F., Riccio A.M., Guerra L., Gamalero C., Zolezzi A., Tarantini F., De Giovanni B., Folli C., Descalzi D., and Canonica G.W. Clara cell 16 protein in COPD sputum: a marker of small airways damage?. Respir. Med. 101 (2007) 2119-2124
60. Kotton D.N., Summer R.S., Sun X., Ma B.Y., and Fine A. Stem cell antigen-1 expression in the pulmonary vascular endothelium. Am. J. Physiol. Lung Cell Mol. Physiol. 284 (2003) L990-L996
61. Balansky R., Izzotti A., D'Agostini F., Camoirano A., Bagnasco M., Lubet R.A., and De Flora S. Systemic genotoxic effects produced by light, and synergism with cigarette smoke in the respiratory tract of hairless mice. Carcinogenesis 24 (2003) 1525-1532
62. Izzotti A., Cartiglia C., Longobardi M., Balansky R., D'Agostini F., Lubet R.A., and De Flora S. Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke. FASEB J. 18 (2004) 1559-1561 (Full text published online, 2 August 2004)
63. Herrmann G., Wlaschek M., Lange T.S., Prenzel K., Goerz G., and Scharffetter-Kochanek K. UVA irradiation stimulates the synthesis of various matrix-metalloproteinases (MMPs) in cultured human fibroblasts. Exp. Dermatol. 2 (1993) 92-97
64. Cork M.J., Crane A.M., and Duff G.W. Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. Dermatol. Clin. 14 (1996) 671-678
65. Botchkarev V.A., Komarova E.A., Siebenhaar F., Botchkareva N.V., Sharov A.A., Komarov P.G., Maurer M., Gudkov A.V., and Gilchrest B.A. P53 Involvement in the control of murine hair follicle regression. Am. J. Pathol. 158 (2001) 1913-1919
66. Balansky R., D'Agostini F., Ganchev G., Izzotti A., Di Marco B., Lubet R.A., Zanesi N., Croce C.M., and De Flora C.S. Influence of FHIT on benzo(a)pyrene-induced tumors and alopecia in mice. Chemoprevention by budesonide and N-acetylcysteine. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7823-7828
67. Fong L.Y., Fidanza V., Zanesi N., Lock L.F., Siracusa L.D., Mancini R., Siprashvili Z., Ottey M., Martin S.E., Druck T., McCue P.A., Croce C.M., and Huebner K. Muir-Torre-like syndrome in Fhit-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4742-4747
68. Wattenberg L.W., Wiedmann T.S., Estensen R.D., Zimmerman C.L., Galbraith A.R., Steele V.E., and Kelloff G.J. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 21 (2000) 179-182
69. Bodó E., Tobin D.J., Kamenisch Y., Bíró T., Berneburg M., Funk W., and Paus R. Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am. J. Pathol. 171 (2007) 1153-1167
70. Cece R., Cazzaniga S., Morelli D., Sfondrini L., Bignotto M., Ménard S., Colnaghi M.I., and Balsari A. Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats. Lab. Invest. 75 (1996) 601-609
71. D'Agostini F., Bagnasco M., Giunciuglio D., Albini A., and De Flora S. Oral N-acetylcysteine inhibition of doxorubicin-induced clastogenicity and alopecia: Interaction between the two drugs in preventing primary tumors and lung micrometastases in mice. Int. J. Oncol. 13 (1998) 217-224
72. D'Agostini F., Balansky R., Pesce C.M., Fiallo P., Lubet R.A., Kelloff G.J., and De Flora S. Induction of alopecia in mice exposed to cigarette smoke. Toxicol. Lett. 114 (2000) 117-123
73. D'Agostini F., Fiallo P., Pennisi T.M., and De Flora S. Chemoprevention of smoke-induced alopecia in mice by oral administration of l-cystine and vitamin B6. J. Dermatol. Sci. 46 (2007) 189-198
74. Trüeb R.M. Association between smoking and hair loss: another opportunity for health education against smoking?. Dermatology 206 (2003) 189-191
75. Su L.H., and Chen T.H. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch. Dermatol. 143 (2007) 1401-1406
76. De Flora S., Izzotti A., Walsh D., Degan P., Petrilli G.L., and Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 11 (1997) 1021-1031
77. De Flora S., and Izzotti A. Mutagenesis and cardiovascular diseases. Molecular mechanisms, risk factors, and protective factors. Mutat. Res. 621 (2007) 5-17
78. World Health Organization, Classification of atherosclerotic lesions, WHO Tech. Rep. Serv. 143 (1985) 1-20.
79. Ross R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340 (1999) 115-126
80. Ramos K.S., Chacon E., and Acosta Jr. D. Toxic responses of the heart and vascular systems. In: Klaassen C.D. (Ed). Casarett and Doull's Toxicology. The Basic Science of Poisons (1996), McGraw-Hill, New York, USA 487-527
81. Trosko J., and Chang C. An integrative hypothesis linking cancer, diabetes, and atherosclerosis: The role of mutations and epigenetic changes. Med. Hypoth. 6 (1980) 455-468
82. B.A. Bridges, D.E. Bowyer, E.S. Hansen, A. Penn, K. Wakabayashi, Report of the ICPEMC Subcommittee 7/1. The Possible Involvement of Somatic Mutations in the Development of Atherosclerotic Plaques (special issue), Mutat. Res. 239 (1990) 143-187.
83. Andreassi M.G., Botto N., Colombo M.G., Biagini A., and Clerico A. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases?. Environ. Mol. Mutagen. 35 (2000) 265-269
84. Izzotti A., De Flora S., Petrilli G.L., Gallagher J., Rojas M., Alexandrov K., Bartsch H., and Lewtas J. Cancer biomarkers in human atherosclerotic lesions. I. Detection of DNA adducts. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 105-110
85. Bogliolo M., Izzotti A., De Flora S., Carli C., Abbondandolo A., and Degan P. Detection of the "4977 bp" mitochondrial DNA deletion in human atherosclerotic lesions. Mutagenesis 14 (1999) 77-82
86. Nair J., De Flora S., Izzotti A., and Bartsch H. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. Mutat. Res. 621 (2007) 95-105
87. Binková B., Smerhovsky Z., Strejc P., Boubelík O., Stávková Z., Chvátalová I., and Srám R.J. DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat. Res. 501 (2002) 115-128
88. Zhang Y.J., Weksler B.B., Wang L., Schwartz J., and Santella R.M. Immunohistochemical detection of polycyclic aromatic hydrocarbon-DNA damage in human blood vessels of smokers and non-smokers. Atherosclerosis 140 (1998) 325-331
89. Izzotti A., Piana A., Minniti G., Vercelli M., Perrone L., and De Flora S. Survival of atherosclerothic patients as related to oxidative stress and gene polymorphisms. Mutat. Res. 621 (2007) 119-128
90. Izzotti A., Cartiglia C., Lewtas J., and De Flora S. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J. 15 (2001) 752-757
91. Chen Z., and Boreham J. Smoking and cardiovascular disease. Semin. Vasc. Med. 2 (2002) 143-252
92. Teo K.K., Ounpuu S., Hawken S., Pandey L.R., Valentin V., Hunt D., Diaz R., Rashed W., Freeman R., Jiang L., Zhang X., Yusuf S., and INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368 (2006) 647-658
93. Izzotti A., Camoirano A., Cartiglia C., Tampa E., and De Flora S. Formation of DNA adducts in the aorta of smoke-exposed rats. Modulation by five chemopreventive agents. Mutat. Res. 494 (2001) 97-106
94. Van Schooten F.J., Hirvonen A., Maas L.M., de Mol B.A., Kleinjans J.C.S., Bell D.A., and Durrer J.D. Putative susceptibility markers of coronary artery diseases: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J. 12 (1998) 1409-1417
95. 32P-postlabeling assay. J. Natl. Cancer Inst. 81 (1989) 341-347
96. Lewtas J., Mumford J., Everson R.B., Hulka B., Wilcosky T., Kozumbo W., Thompson C., George M., Dobias L., Sram R., Li X., and Gallagher J. Comparison of DNA adducts from complex mixture exposures in various human tissues and experimental systems. Environ. Health Perspect. 99 (1993) 88-97
97. Gaubatz J.W. DNA damage during aging of mouse myocardium. J. Mol. Cell Cardiol. 18 (1986) 1317-1320
98. Randerath E., Mittal D., and Randerath K. Tissue distribution of covalent DNA damage in mice treated dermally with cigarette "tar". Preference for lung and heart DNA. Carcinogenesis 9 (1988) 75-80
99. Gairola C.G., and Gupta R.C. Cigarette smoke-induced DNA adducts in the respiratory and nonrespiratory tissues of rats. Environ. Mol. Mutagen. 17 (1991) 253-257
100. Övervik E., Ochiai M., Hirose M., Sugimura T., and Nagao M. The formation of heart DNA adducts in F344 rats following dietary administration of heterocyclic amines. Mutat. Res. 256 (1991) 37-43
101. Izzotti A., Bagnasco M., D'Agostini F., Cartiglia C., Lubet R.A., Kelloff G.J., and De Flora S. Formation and persistence of nucleotide alterations in rats exposed whole-body to environmental cigarette smoke. Carcinogenesis 20 (1999) 1499-1505
102. Putnam J.B., Sweeney M.S., Colon R., Lanza R.A., Frazier O.H., and Cooley D.A. Primary cardiac sarcomas. Ann. Thorac. Surg. 51 (1991) 906-910
103. Tam S.K., Gu W., Mahdavi V., and Nadal-Ginard B. Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann. N.Y. Acad. Sci 752 (1994) 72-79
104. Hartz A.J., Anderson A.J., Brooks H.L., Manley J.C., Parent G.D., and Barboriak J.J. The association of smoking with cardiomyopathy. N. Engl. J. Med. 311 (1984) 1201-1206
105. Gvozdjáková A., Bada V., Sány L., Kucharská J., Krutý F., Bozek P., Trstanský L., and Gvozdják J. Smoke cardiomyopathy: disturbance of oxidative processes in myocardial mitochondria. Cardiovasc. Res. 18 (1984) 229-232
106. Leone A. Biochemical markers of cardiovascular damage from tobacco smoke. Curr. Pharm. Des. 11 (2005) 2199-2208
107. Izzotti A., Balansky R.M., Blagoeva P.M., Mircheva Z.I., Tulimiero L., Cartiglia C., and De Flora S. DNA alterations in rat organs following chronic exposure to cigarette smoke and/or ethanol ingestion. FASEB J. 12 (1998) 753-758
108. Izzotti A., Balansky R., D'Agostini F., Bennicelli C., Myers S.R., Grubbs C.J., Lubet R.A., Kelloff G.J., and De Flora S. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res. 61 (2001) 2472-2479